» Articles » PMID: 33188013

Dedifferentiation and Neuronal Repression Define Familial Alzheimer's Disease

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2020 Nov 14
PMID 33188013
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Identifying the systems-level mechanisms that lead to Alzheimer's disease, an unmet need, is an essential step toward the development of therapeutics. In this work, we report that the key disease-causative mechanisms, including dedifferentiation and repression of neuronal identity, are triggered by changes in chromatin topology. Here, we generated human induced pluripotent stem cell (hiPSC)-derived neurons from donor patients with early-onset familial Alzheimer's disease (EOFAD) and used a multiomics approach to mechanistically characterize the modulation of disease-associated gene regulatory programs. We demonstrate that EOFAD neurons dedifferentiate to a precursor-like state with signatures of ectoderm and nonectoderm lineages. RNA-seq, ATAC-seq, and ChIP-seq analysis reveals that transcriptional alterations in the cellular state are orchestrated by changes in histone methylation and chromatin topology. Furthermore, we demonstrate that these mechanisms are observed in EOFAD-patient brains, validating our hiPSC-derived neuron models. The mechanistic endotypes of Alzheimer's disease uncovered here offer key insights for therapeutic interventions.

Citing Articles

Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease.

Valdes P, Caldwell A, Liu Q, Fitzgerald M, Ramachandran S, Karch C Alzheimers Res Ther. 2025; 17(1):5.

PMID: 39754192 PMC: 11699654. DOI: 10.1186/s13195-024-01659-6.


Macroscale connectome topographical structure reveals the biomechanisms of brain dysfunction in Alzheimer's disease.

Zhao K, Wang D, Wang D, Chen P, Wei Y, Tu L Sci Adv. 2024; 10(41):eado8837.

PMID: 39392880 PMC: 11809497. DOI: 10.1126/sciadv.ado8837.


pyPAGE: A framework for Addressing biases in gene-set enrichment analysis-A case study on Alzheimer's disease.

Bakulin A, Teyssier N, Kampmann M, Khoroshkin M, Goodarzi H PLoS Comput Biol. 2024; 20(9):e1012346.

PMID: 39236079 PMC: 11421795. DOI: 10.1371/journal.pcbi.1012346.


Xenografted human iPSC-derived neurons with the familial Alzheimer's disease APP mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator.

Qu W, Lam M, McInvale J, Mares J, Kwon S, Humala N Acta Neuropathol. 2024; 147(1):107.

PMID: 38918213 PMC: 11199265. DOI: 10.1007/s00401-024-02755-5.


A novel APP splice variant-dependent marker system to precisely demarcate maturity in SH-SY5Y cell-derived neurons.

Kulatunga D, Ranaraja U, Kim E, Kim R, Kim D, Ji K Sci Rep. 2024; 14(1):12113.

PMID: 38802572 PMC: 11130256. DOI: 10.1038/s41598-024-63005-y.


References
1.
Lee S, Cook D, Lawrence M . plyranges: a grammar of genomic data transformation. Genome Biol. 2019; 20(1):4. PMC: 6320618. DOI: 10.1186/s13059-018-1597-8. View

2.
Tanzi R . The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012; 2(10). PMC: 3475404. DOI: 10.1101/cshperspect.a006296. View

3.
Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

4.
Satoh J, Kawana N, Yamamoto Y . ChIP-Seq Data Mining: Remarkable Differences in NRSF/REST Target Genes between Human ESC and ESC-Derived Neurons. Bioinform Biol Insights. 2013; 7:357-68. PMC: 3855043. DOI: 10.4137/BBI.S13279. View

5.
Hyun K, Jeon J, Park K, Kim J . Writing, erasing and reading histone lysine methylations. Exp Mol Med. 2017; 49(4):e324. PMC: 6130214. DOI: 10.1038/emm.2017.11. View